ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Deposits
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Deposits of -$60.54 thousand for the 116-month period ending 2012-12-31, per its 10-Q filed 2013-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeposits · last filed 2013-02-13
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deposits for the quarter ending 2010-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deposits for fiscal 2012 was -$23.75K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in deposits for fiscal 2010 was $60.10K.
| Period end | Increase (Decrease) in Deposits 3 month | Increase (Decrease) in Deposits 6 month | Increase (Decrease) in Deposits 9 month | Increase (Decrease) in Deposits 12 month | Increase (Decrease) in Deposits 98 month | Increase (Decrease) in Deposits 101 month | Increase (Decrease) in Deposits 104 month | Increase (Decrease) in Deposits 107 month | Increase (Decrease) in Deposits 110 month | Increase (Decrease) in Deposits 113 month | Increase (Decrease) in Deposits 116 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | -$60.54K 10-Q · filed 2013-02-13 | ||||||||||
| 2012-09-30 | -$23.75K 10-K · filed 2012-12-28 | -$60.54K 10-K · filed 2012-12-28 | |||||||||
| 2012-06-30 | -$36.80K 10-Q · filed 2012-08-13 | ||||||||||
| 2012-03-31 | -$36.80K 10-Q · filed 2012-05-08 | ||||||||||
| 2011-12-31 | -$36.80K 10-Q · filed 2012-02-09 | ||||||||||
| 2011-09-30 | -$36.80K 10-Q · filed 2012-08-13 | ||||||||||
| 2011-06-30 | -$36.80K 10-Q · filed 2011-08-08 | ||||||||||
| 2011-03-31 | -$32.76K 10-Q · filed 2012-05-08 | ||||||||||
| 2010-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $60.10K 10-K · filed 2011-12-20 | |||||||||
| 2010-06-30 | $60.10K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |